[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4761 Introduced in House (IH)]
<DOC>
116th CONGRESS
1st Session
H. R. 4761
To ensure U.S. Customs and Border Protection officers, agents, and
other personnel have adequate synthetic opioid detection equipment,
that the Department of Homeland Security has a process to update
synthetic opioid detection capability, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
October 18, 2019
Mr. Higgins of Louisiana (for himself, Ms. Clarke of New York, Mr.
Rogers of Alabama, Mr. Katko, Mr. Rose of New York, Mr. King of New
York, Mr. Joyce of Pennsylvania, and Mr. McCaul) introduced the
following bill; which was referred to the Committee on Homeland
Security, and in addition to the Committee on Ways and Means, for a
period to be subsequently determined by the Speaker, in each case for
consideration of such provisions as fall within the jurisdiction of the
committee concerned
_______________________________________________________________________
A BILL
To ensure U.S. Customs and Border Protection officers, agents, and
other personnel have adequate synthetic opioid detection equipment,
that the Department of Homeland Security has a process to update
synthetic opioid detection capability, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``DHS Opioid Detection Resilience Act
of 2019''.
SEC. 2. STRATEGY TO ENSURE DETECTION OF ALL OPIOID PURITY LEVELS AT
PORTS OF ENTRY.
Not later than 180 days after the date of the enactment of this
section, the Commissioner of U.S. Customs and Border Protection (CBP)
shall--
(1) implement a strategy to ensure deployed chemical
screening devices are able to identify in an operational
environment narcotics at purity levels less than or equal to 10
percent, or provide ports of entry with an alternate method for
identifying narcotics at lower purity levels; and
(2) require testing of any new chemical screening devices
to understand the abilities and limitations of such devices
relating to identifying narcotics at various purity levels
before CBP commits to the acquisition of such devices.
SEC. 3. PLAN TO ENSURE OPIOID DETECTION EQUIPMENT RESILIENCY.
Not later than 180 days after the date of the enactment of this
section, the Secretary of Homeland Security shall implement a plan for
the long-term development of a centralized spectral database for
chemical screening devices. Such plan shall address the following:
(1) How newly identified spectra will be collected, stored,
and distributed to such devices in their operational
environment, including at ports of entry.
(2) Identification of parties responsible for updates and
maintenance of such database.
<all>